Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Harvest One Cannabis (TSXV:HVT) subsidiary, Satipharm, has expanded its CBD Gelpell products portfolio
  • The company has introduced two new variants to its CBD Advanced range, called Active and Focus
  • The products come in microbead capsules, and deliver various benefits for physical and mental health
  • Satipharm’s products are currently on sale in major retailers and pharmacy chains in the UK and Ireland
  • Harvest One Cannabis (HVT) is up 7.69 per cent, and is currently trading for C$0.07 per share

Harvest One Cannabis (TSXV:HVT) subsidiary, Satipharm, has expanded its CBD Advanced Gelpell products portfolio with two new additions.

Satipharm’s CBD Advanced product range consists of proprietary Gelpell capsules, containing CBD and beneficial vitamins.

The patented technology delivers CBD in microbeads, which studies have shown to improve absorption into a person’s circulation. 

Compared to standard CBD oils, Satipharm’s Gelpell capsules have 3.5 times higher bioavailability. This means that the product is arguably more effective, as a greater portion of the substance is absorbed. 

The Gelpell capsule has undergone Stage I and II clinical trials. Two peer-reviewed international medical journals published the result of those trials. 

The company’s two new variants of the range are called Active and Focus. Active, which combines CBD with vitamins A, D, E, and K, supports general body health and movement.

Focus, which combines CBD with vitamin B, supports mental wellbeing. Both of the new additions use the proprietary Gelpell delivery formula.

The company’s product portfolio currently sells in major retailer and pharmacy chains throughout the UK and Ireland. Still, Harvest One and Satipharm have plans to expand further. 

Harvest One’s CEO, Andy Bayfield, commented that a differentiated product offering is key to building a successful brand.

“We continue to expand our distribution with major retailers and pharmacy chains throughout the United Kingdom and Ireland.

“These innovative new product variations, Active and Focus, offer our consumers solutions to specific needs, while leveraging our proven Gelpell delivery technology,” he said. 

Harvest One Cannabis (HVT) is up 7.69 per cent, and trading for 7 cents per share, as of 10:26am EST.

More From The Market Herald
BioHarvest - CEO, Ilan Sobel

" BioHarvest Sciences (CSE:BHSC) exploring opportunities to sell its cannabis products in the Canadian market

BioHarvest Sciences (BHSC) is exploring opportunities to acquire an existing licensed facility or a Licensed Producer in Canada.
HEXO - CEO, Scott Cooper.

" HEXO (TSX:HEXO) delineates its path forward

HEXO (HEXO) has announced cost-saving initiatives to carry the company into the future.

" Tinley’s (CSE:TNY) makes production announcement, closes first tranche of private placement

The Tinley Beverage Company (TNY) will begin making Green Monké products at its Long Beach facility.

" Tinley (CSE:TNY) announces first product clearance under California distribution license

The Tinley Beverage Company (TNY) has released an update regarding products manufactured at its Long Beach facility.